Evidence map›Paper›PMID 30617735›Full record

Trial reportJournal of bioenergetics and biomembranes2019

Post-stroke fatigue as an indicator of underlying bioenergetics alterations.

N Jennifer Klinedinst, Rosemary Schuh, Steven J Kittner, William T Regenold, Glenn Kehs, Christine Hoch, Alisha Hackney, Gary Fiskum

Registry-linked trialAbstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Journal of bioenergetics and biomembranes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04580238 (Onabotulinum Toxin A), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04580238 phase1withdrawnnot on this mapstarted 2023, after this paper: background citation

Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache

TypeinterventionalSponsorUniversity of AlbertaRan2023 to 2025Enrolled0ConditionsStroke (CVA) or TIA, Headache, Migraine, Botulinum Toxins, Type A, Cerebral Venous Sinus ThrombosisArmsBotox 200 UNT Injection, Non Botox based Standard of Care Treatments for Headache/Migraine
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Energy metabolism in health and diseases.Signal transduction and targeted therapy · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

N Jennifer KlinedinstUniversity of Maryland School of Nursing, Room 325B, 655 W. Lombard Street, Baltimore, MD, 21201, USA. klinedinst@umaryland.edu.ORCID 0000-0003-0080-1396
Rosemary SchuhUniversity of Maryland School of Medicine, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.
Steven J KittnerUniversity of Maryland School of Medicine, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.
William T RegenoldUniversity of Maryland School of Medicine, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.
Glenn KehsUniversity of Maryland School of Medicine, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.
Christine HochUniversity of Maryland School of Nursing, Room 325B, 655 W. Lombard Street, Baltimore, MD, 21201, USA.
Alisha HackneyUniversity of Maryland School of Nursing, Room 325B, 655 W. Lombard Street, Baltimore, MD, 21201, USA.
Gary FiskumUniversity of Maryland School of Medicine, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.
University of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Approximately half of stroke survivors suffer from clinically significant fatigue, contributing to poor quality of life, depression, dependency, and increased mortality. The etiology of post-stroke fatigue is not well understood and treatment is limited. This study tested the hypothesis that systemic aerobic energy metabolism, as reflected by platelet oxygen consumption, is negatively associated with fatigue and systemic inflammation is positively associated with fatigue in chronic ischemic stroke survivors. Data on self-reported level of fatigue, platelet oxygen consumption rates (OCR) and plasma inflammatory markers were analyzed from 20 ischemic stroke survivors. DNA copy number for two mitochondrial genes was measured as a marker of platelet mitochondrial content. Basal and protonophore-stimulated maximal platelet OCR showed a biphasic relationship to fatigue. Platelet OCR was negatively associated with low to moderate fatigue but was positively associated with moderate to high fatigue. DNA copy number was not associated with either fatigue or platelet OCR. Fatigue was negatively associated with C-reactive protein but not with other inflammatory markers. Post-stroke fatigue may be indicative of a systemic cellular energy dysfunction that is reflected in platelet energy metabolism. The biphasic relationship of fatigue to platelet OCR may indicate an ineffective bioenergetic compensatory response that has been observed in other pathological states.

Indexed as

Energy MetabolismOxygen ConsumptionAgedAged, 80 and overBiomarkersBlood PlateletsBrain IschemiaChronic DiseaseFatigueFemaleHumansMaleMiddle AgedStrokeBiomarkersBioenergeticsFatigueInflammationIschemic strokePlatelets

Identifiers

PMID30617735
OpenAlexW2908773557

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.